Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma.

Vogelzang NJ, Karrison T, Stadler WM, Garcia J, Cohn H, Kugler J, Troeger T, Giannone L, Arrieta R, Ratain MJ, Vokes EE. A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma. Cancer. 2004 Jan 01; 100(1):65-71.

View in: PubMed